Saturday, October 24, 2020
wellness India Expo
Home Tags Oncology

Tag: Oncology

“Plasma therapy needs to be explored, may turn out to be...

Dr Shekhar Kirani, Spokesperson, ACT Grants and Dr Vishal Rao  Regional Director, Head Neck Surgical Oncology and Robotic Surgery, HCG share their views on the initiative to build a plasma bank and a plasma council besides various other aspects related to plasma therapy....................

Cipla expands partnership with Roche Pharma to improve access to key...

Cipla signs a distribution agreement with Roche Products (India) Pvt. Ltd. to expand scope of the partnership to include, marketing and distribution of Roche’s trademark oncology drugs - Trastuzumab (Herclon), Bevacizumab (Avastin) and Rituximab (Ristova) in India.........................

CSIR’s anti-pancreatic cancer drug IIIM-290 gets approval for clinical trial

Approval from the New Drugs Division of Central Drugs Standard Control Organization (CDSCO) will pave way for CSIR-Indian Institute of Integrative Medicine (IIIM) Jammu for conducting the clinical trial of this important drug candidate IIIM-290 in pancreatic cancer patients....................

Oncocyte ties up with CORE Diagnostics to market its cancer testing...

In the United States, DetermaRx™ has rapidly gained traction, expanding to 18 sites in the first three months since commercial launch. The company is now is expanding commercial availability of DetermaRx™ to India, the Middle East and Africa..................

Organoids market to grow 4X as researchers transition from 2D to...

According to the latest market intelligence report, the global organoids market is expected to reach ~ US$ 134 Mn by the forecast year 2029.....................

MedGenome expands its presence in Mumbai by taking over Centre For...

With this take over, it will be able to provide patients with a wide range of molecular tests across all the specialties like Reproductive, Neurology, Nephrology, Oncology, Cardiology, ENT, Endocrinology, Ophthalmology, rare diseases etc...…………..

Biocon’s indigenous biologic for head & neck cancer a viable solution,...

At a panel discussion held by the Biocon at New Delhi, the leading oncologists deliberated on the results of a large scale clinical study on novel biologic, BioMab EGFR (Nimotuzumab) for head and neck cancer and its impact as a targeted therapy on patient outcomes

Pricing adjustments for CAR-T therapies likely to take place in 2018,...

A fairly comprehensive study reported in February 2018 on the Health Affairs Blog claims that Novartis could lower the price of Kymriah by two-thirds and still achieve a profit..................

Govt mulling PPP model cancer detection centers with Tata Trust

While speaking at an ASSOCHAM event, Mr Ashwini Kumar Choubey, Minister of State for Health and Family Welfare revealed that his ministry will establish cancer detection centers with Tata Trust in states like Bihar, Jharkhand and Chattisgarh...........

India’s first digital online oncology tutorial launched

Ms Preeti Sudan, Secretary, Health and Family Welfare on 4th January launched the country’s first digital Online Oncology Tutorial Series designed by the Tata Memorial Center in collaboration with the Health Ministry............